Provider & product review
Pallas Health NAD+ Review: Four-Week Pricing and Care
Pallas NAD+ injection lists $139 initially, then $179 every four weeks. Understand the renewal cadence, annual-plan headline, included care and evidence limits.
Pallas Health advertises NAD+ injections at $139 for the first month, then $179 every four weeks. Provider care is included, and the landing page says payment is charged only if a clinician prescribes. The recurring four-week amount is the useful figure for comparing its ordinary plan.
Its annual plan advertises a $119 monthly average. A monthly equivalent on a longer commitment is different from a small monthly payment: confirm the actual prepaid amount, shipment schedule and refund conditions before choosing that option.
What the renewal schedule means
Every four weeks means a 28-day interval. Thirteen such intervals fit into 52 weeks, so a full 52-week stretch at the $179 standing rate costs $2,327, rather than twelve payments totaling $2,148. That is approximately $194 per calendar month when you spread the 52-week cost over twelve months.
The introductory period makes an individual first-year total different; the actual enrollment date, first renewal and chosen plan determine the charges. The $2,327 comparison describes thirteen ordinary renewal periods, not an exact prediction of your first-year bill.
Published NAD+ plan prices
| Plan | Published price | Commitment |
|---|---|---|
| First month | $139 | Introduction |
| Renewal | $179 | Every four weeks |
| Annual headline | $119/month average | Confirm prepaid total |
The public offer is materially different from older twelve-week billing descriptions. Use the current four-week terms shown at enrollment, and keep a copy of the price, cancellation cutoff and renewal schedule you agree to.
On this page
What is included, and what needs confirmation?
The NAD+ landing page describes clinician-personalized dosing, provider care and free expedited shipping. It says treatment renews until canceled, and that nothing is charged unless a clinician prescribes. These are useful commercial disclosures, although approval, timing and medication choice remain clinical decisions.
The landing page does not establish a particular vial quantity for every patient or clearly settle whether baseline and follow-up laboratory work are included. Ask for the total prescribed milligrams, concentration, supplies and any separate lab or visit charges. A flat advertised plan price is easier to compare when the supplied medication is specified.
Pharmacy and state eligibility
Pallas describes its medication as dispensed by independent US-licensed compounding pharmacies. Confirm the pharmacy actually assigned to your prescription and its contact details. A provider's general pharmacy description does not establish that a particular compounded preparation is FDA-approved.
The homepage advertises services in all 50 states and Washington, D.C., and explains that some states require a video visit. That sitewide claim does not guarantee every treatment for every applicant. Ask whether the NAD+ program, prescribing clinician and dispensing pharmacy serve your location, and whether a required video visit has a separate charge or deposit.
We have not treated an absent FDA search result as certification of a clean enforcement history. Medical licensing, pharmacy authorization and warning-letter status are distinct checks, and a retail telehealth brand should not be treated as interchangeable with its clinical or pharmacy partners.
NAD+ evidence and brain fog
Pallas presents NAD+ as an energy and longevity option. The fact that NAD+ participates in cellular metabolism does not show that buying an injection improves your concentration or addresses the cause of brain fog.
Randomized trials of an oral NAD+ precursor in people with cognitive concerns did not establish improved cognition12. Those studies do not validate this compounded injection. An intravenous pilot measured metabolites without establishing a cognitive benefit3. Our NAD+ brain-fog evidence review explains the distinction between a biochemical effect and a patient benefit.
If your main concern is persistent foggy thinking, start with common causes of brain fog and a clinical assessment. Provider care can help assess eligibility for a prescription; it is not proof that the proposed treatment will help your symptoms.
Who might consider Pallas?
Pallas may appeal to someone who wants a published injection price with provider care included and is comfortable with four-week auto-renewal. Its current commercial terms are easier to assess when you compare the standing rate instead of the first-month promotion or annual-plan average.
Use our NAD+ injection comparison to compare medication quantity, renewal cadence and support, then confirm the final terms directly with the provider. This is a review of public offers and disclosures; we did not order or use the medication.
A few gentle questions
How much does Pallas Health NAD+ cost?
The current injection landing page lists $139 for the first month, then $179 every four weeks, with provider care included. It also advertises a $119 monthly average on an annual plan; confirm the actual prepaid total and terms.
Is every four weeks the same as monthly?
No. Four weeks is 28 days. Thirteen $179 payments over 52 weeks total $2,327, rather than twelve payments totaling $2,148. The introductory period and selected plan affect actual first-year charges.
Is the provider visit included?
The NAD+ landing page says provider care is included and payment is charged only if a clinician prescribes. Confirm whether required video visits, laboratory work or other services carry separate costs.
Which pharmacy dispenses Pallas NAD+?
Pallas describes independent US-licensed compounding pharmacies. Confirm the actual dispensing pharmacy for your prescription rather than assuming a general partner list identifies your supplier.
Does Pallas serve my state?
Its homepage advertises nationwide services and explains that some states require a video visit. Confirm availability of the particular NAD+ program, clinician and pharmacy in your state.
Is Pallas NAD+ proven to improve cognition?
No rigorous human cognition trial establishes a benefit from its compounded NAD+ injection. Cellular-metabolism explanations and precursor studies do not demonstrate a clinical benefit for this product.
Where this comes from
- Orr ME, Kotkowski E, Ramirez P, Bair-Kelps D, Liu Q, Brenner C, et al. (2024). A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience. 2024;46(1):665-682. https://pubmed.ncbi.nlm.nih.gov/37994989/
- Wu CY, Kupferschmid AC, Chen L, McManus AJ, Kivisäkk P, Galler JA, et al. (2025). Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment. Alzheimers Dement (N Y). 2025;11(1):e70023. https://pubmed.ncbi.nlm.nih.gov/39817194/
- Grant R, Berg J, Mestayer R, Braidy N, Bennett J, Broom S, et al. (2019). A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+. Frontiers in Aging Neuroscience. 2019;11:257. https://pubmed.ncbi.nlm.nih.gov/31572171/
- Pallas Health (2026). NAD+ public plans and pricing. www.pallashealth.co/lp/nad. https://www.pallashealth.co/lp/nad
- Pallas Health (2026). Public service and state-availability information. pallashealth.co. https://www.pallashealth.co/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Read on, gently
MyDrHank NAD+ Review: Starting Price, Care and Plan Questions
MyDrHank advertises NAD+ from $137/month, depending on protocol and dose. Compare included care, renewal questions, pharmacy disclosures and evidence limits.
ReadHealthRX NAD+ Review: $161 Injection Plan and What Is Included
HealthRX publishes NAD+ prices, injection quantity, and prepay terms. Our review checks the $161 plan, nasal option, refunds, and evidence limits.
ReadStrut Health NAD+ Review: The Page Describes the Wrong Molecule
Strut sells a 500 mg NAD+ injection from $149 and prints the dose — then explains NAD+ as a peptide that signals the pituitary. It isn't one.
ReadHe & She MD NAD+ Review: Monthly and Annual Plan Pricing
He & She MD lists NAD+ at $229 monthly or a $139 annual-plan equivalent. Compare commitments, conflicting price copy and questions to ask before enrollment.
ReadOak NAD+ Review: Published Pricing, Included Care and Questions
Oak now advertises NAD+ injections from $175/month. Review included care, the regular $199 price, pharmacy questions and the limits of the evidence.
ReadEnhance MD NAD+ Review: Read the Four-Week Billing First
Enhance MD offers NAD+ injections and wafers. We compare four-week billing, longer plans, support, pharmacy disclosures and the limits of the evidence.
Read